181 related articles for article (PubMed ID: 28683829)
21. Efficacy and Safety of Miglitol- or Repaglinide-Based Combination Therapy with Alogliptin for Drug-Naïve Patients with Type 2 Diabetes: An Open-Label, Single-Center, Parallel, Randomized Controlled Pilot Study.
Okajima F; Sugihara H; Emoto N
J Nippon Med Sch; 2021 Mar; 88(1):71-79. PubMed ID: 32475902
[TBL] [Abstract][Full Text] [Related]
22. The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus.
Osonoi T; Saito M; Mochizuki K; Fukaya N; Muramatsu T; Inoue S; Fuchigami M; Goda T
Metabolism; 2010 Dec; 59(12):1816-22. PubMed ID: 20667563
[TBL] [Abstract][Full Text] [Related]
23. Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus.
Mitrakou A; Tountas N; Raptis AE; Bauer RJ; Schulz H; Raptis SA
Diabet Med; 1998 Aug; 15(8):657-60. PubMed ID: 9702468
[TBL] [Abstract][Full Text] [Related]
24. [Usefulness of miglitol in patients with diabetes mellitus type 2 and insufficient control of the blood glucose].
de Luis Román DA; del Pozo García E; Aller R; Romero Bobillo E; Conde Valentín R
Rev Clin Esp; 2004 Jan; 204(1):32-4. PubMed ID: 14746760
[TBL] [Abstract][Full Text] [Related]
25. Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients.
Johnston PS; Coniff RF; Hoogwerf BJ; Santiago JV; Pi-Sunyer FX; Krol A
Diabetes Care; 1994 Jan; 17(1):20-9. PubMed ID: 8112185
[TBL] [Abstract][Full Text] [Related]
26. Additive effects of miglitol and anagliptin on insulin-treated type 2 diabetes mellitus: a case study.
Kishimoto M; Noda M
Clin Drug Investig; 2015 Feb; 35(2):141-7. PubMed ID: 25511640
[TBL] [Abstract][Full Text] [Related]
27. Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type II diabetic patients?
Johnson AB; Taylor R
Diabetes Care; 1996 Jun; 19(6):559-63. PubMed ID: 8725851
[TBL] [Abstract][Full Text] [Related]
28. Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial.
Xu S; Liu X; Ming J; Ji Q
Trials; 2016 Mar; 17():160. PubMed ID: 27009108
[TBL] [Abstract][Full Text] [Related]
29. Treatment with the α-glucosidase inhibitor miglitol from the preonset stage in Otsuka Long-Evans Tokushima Fatty rats improves glycemic control and reduces the expression of inflammatory cytokine genes in peripheral leukocytes.
Mochizuki K; Fukaya N; Tanaka Y; Fuchigami M; Goda T
Metabolism; 2011 Nov; 60(11):1560-5. PubMed ID: 21550076
[TBL] [Abstract][Full Text] [Related]
30. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
Ishibashi K; Hara A; Fujitani Y; Uchida T; Komiya K; Tamaki M; Abe H; Ogihara T; Kanazawa A; Kawamori R; Watada H
Biochem Biophys Res Commun; 2013 Nov; 440(4):570-5. PubMed ID: 24103756
[TBL] [Abstract][Full Text] [Related]
31. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
[TBL] [Abstract][Full Text] [Related]
32. Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients.
Pagano G; Marena S; Corgiat-Mansin L; Cravero F; Giorda C; Bozza M; Rossi CM
Diabete Metab; 1995 Jun; 21(3):162-7. PubMed ID: 7556806
[TBL] [Abstract][Full Text] [Related]
33. N-Hydroxyethyl-1-Deoxynojirimycin (Miglitol) Restores the Counterregulatory Response to Hypoglycemia Following Antecedent Hypoglycemia.
Jokiaho AJ; Winchester M; Donovan CM
Diabetes; 2022 May; 71(5):1063-1072. PubMed ID: 35179550
[TBL] [Abstract][Full Text] [Related]
34. Effects of miglitol, an alpha-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats.
Goda T; Suruga K; Komori A; Kuranuki S; Mochizuki K; Makita Y; Kumazawa T
Br J Nutr; 2007 Oct; 98(4):702-10. PubMed ID: 17537288
[TBL] [Abstract][Full Text] [Related]
35. Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.
Aoki K; Kamiyama H; Yoshimura K; Shibuya M; Masuda K; Terauchi Y
Acta Diabetol; 2012 Jun; 49(3):225-30. PubMed ID: 21898126
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of reactive hypoglycemia secondary to late dumping syndrome using miglitol.
Fujita Y; Tamada D; Kozawa J; Kobayashi Y; Sasaki S; Kitamura T; Yasuda T; Maeda N; Otsuki M; Okita K; Iwahashi H; Kaneto H; Funahashi T; Imagawa A; Shimomura I
Intern Med; 2012; 51(18):2581-5. PubMed ID: 22989830
[TBL] [Abstract][Full Text] [Related]
37. Comparison of pre- vs. postmeal administration of miglitol for 3 months in type 2 diabetic patients.
Aoki K; Nakajima S; Nezu U; Shinoda K; Terauchi Y
Diabetes Obes Metab; 2008 Sep; 10(10):970-2. PubMed ID: 18721256
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of combined use of miglitol in Type 2 diabetes patients receiving insulin therapy-placebo-controlled double-blind comparative study.
Nemoto M; Tajima N; Kawamori R
Acta Diabetol; 2011 Mar; 48(1):15-20. PubMed ID: 20617348
[TBL] [Abstract][Full Text] [Related]
39. Miglitol: assessment of its role in the treatment of patients with diabetes mellitus.
Campbell LK; Baker DE; Campbell RK
Ann Pharmacother; 2000 Nov; 34(11):1291-301. PubMed ID: 11098345
[TBL] [Abstract][Full Text] [Related]
40. Miglitol may have a blood glucose lowering effect unrelated to inhibition of alpha-glucosidase.
Joubert PH; Foukaridis GN; Bopape ML
Eur J Clin Pharmacol; 1987; 31(6):723-4. PubMed ID: 3549325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]